Cardiometabolic Aging Driven by Multi-Organ Crosstalk: Mechanisms and Therapeutic Strategies
International Journal of Molecular Sciences · 01.08.2026 · 27 (15) · 6881
DOI: 10.3390/ijms27156881 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 01.08.2026. Verfasst von Shouyao Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical School, Yunnan University of Chinese Medicine, Kunming 650500, China. Hauptthemen laut MEDLINE: Aging, Cardiovascular Diseases. Die Arbeit nennt 159 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yunnan University of Traditional Chinese Medicine, Yunnan Key Laboratory of Integrated Traditional Chinese, Western Medicine for Chronic Disease in Prevention and Treatment.
Abstract (Originalsprache)
Cardiac senescence is not an isolated organ decline but a systemic consequence driven by pathological crosstalk between the heart and its peripheral metabolic organs. In this review, we discard the traditional organ–centric perspective and construct an integrated framework around multi-organ crosstalk axes, including the epicardial adipose tissue–heart axis, the skeletal muscle–heart axis, the gut–heart axis, and the kidney–heart axis. For each axis, we dissect the local molecular mediators—inflammatory cytokines, lipotoxic metabolites, microbiota-derived compounds such as trimethylamine N-oxide (TMAO), renin-angiotensin-aldosterone system (RAAS) effectors, and extracellular vesicle (EV) cargoes—and illustrate how they converge onto common pathways of oxidative stress, impaired autophagy, and cellular senescence. Importantly, we emphasize that these signals do not operate in isolation; they act synergistically through the circulation, converting local organ dysfunction into systemic cardiac aging via convergence onto shared senescence pathways. By redefining aging as a potentially modifiable multi-organ crosstalk, we propose emerging nodal points—senolytics, myokine mimetics, gut microbiota modulation, RAAS/sodium–glucose cotransporter 2 (SGLT2) inhibitors, and integrated lifestyle strategies—to block pathological crosstalk and delay cardiovascular aging. This framework shifts the research focus from isolated organs to systemic multi-organ crosstalk, providing new insights into cardiometabolic aging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The First Clinical Medical School, Yunnan University of Chinese Medicine, Kunming 650500, China.
- The Second Clinical Medical School, Yunnan University of Chinese Medicine, Kunming 650500, China.
- School of Basic Medicine, Yunnan University of Chinese Medicine, Kunming 650500, China.
ORCID-Profile: Shouyao Zhang, Xinghe Zhang
Förderung
- Yunnan University of Traditional Chinese Medicine
- Yunnan Key Laboratory of Integrated Traditional Chinese
- Western Medicine for Chronic Disease in Prevention and Treatment
Zitieren
APA
Zhang, S., Xu, C., Song, Y., & Zhang, X. (2026). Cardiometabolic Aging Driven by Multi-Organ Crosstalk: Mechanisms and Therapeutic Strategies. International Journal of Molecular Sciences, 27(15), 6881. https://doi.org/10.3390/ijms27156881
Vancouver
Zhang S, Xu C, Song Y, Zhang X. Cardiometabolic Aging Driven by Multi-Organ Crosstalk: Mechanisms and Therapeutic Strategies. International Journal of Molecular Sciences. 2026;27(15):6881. doi:10.3390/ijms27156881
BibTeX
@article{Zhang2026,
author = {Zhang, Shouyao and Xu, Chenggui and Song, Yongli and Zhang, Xinghe},
title = {Cardiometabolic Aging Driven by Multi-Organ Crosstalk: Mechanisms and Therapeutic Strategies},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {15},
pages = {6881},
doi = {10.3390/ijms27156881}
}
EUVIMED